Condition
Cervical Squamous Cell Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Cervical Squamous Cell Carcinoma clinical trials that are recruiting, at sites in 11 countries (most in United States (4), Singapore (3), Taiwan (3)). By phase: Phase 1/2 (4), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 11Countries
Newest Cervical Squamous Cell Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Blood biomarkers to help detect and monitor cervical cancer | — | Brisbane, Queensland | Recruiting | Sep 1, 2026 |
| EVOLVE104 for advanced bladder and other squamous cell cancers | Phase 1 | Duarte, California and 15 other locations | Recruiting | Oct 15, 2025 |
| ALE.P03 alone for adults with advanced CLDN1-positive solid tumors | Phase 1/2 | Phoenix, Arizona and 40 other locations | Recruiting | Sep 12, 2025 |
| Investigating ALE.P02 for treating specific solid tumors in adults | Phase 1/2 | Scottsdale, Arizona and 40 other locations | Recruiting | Dec 24, 2024 |
| External and internal radiation plus chemotherapy and immunotherapy for Stage IVB cervical cancer | Phase 1/2 | Los Angeles, California and 3 other locations | Recruiting | Aug 9, 2024 |
| Testing a new antibody treatment for advanced squamous cell cancers | Phase 1/2 | Sydney, New South Wales and 19 other locations | Recruiting | Jun 20, 2023 |
All recruiting trials (6)
-
Blood biomarkers to help detect and monitor cervical cancer
This study tests whether a blood test using cfDNA and extracellular vesicles can help detect and track cervical cancer in adult women.
-
EVOLVE104 for advanced bladder and other squamous cell cancers
This will try EVOLVE104, an experimental drug, in adults with advanced or metastatic bladder or other squamous cell cancers who have already tried or cannot take standard treatments.
-
ALE.P03 alone for adults with advanced CLDN1-positive solid tumors
This trial tests whether ALE.P03 given alone is safe and can shrink tumors in adults with advanced CLDN1-positive cancers who have already tried standard treatments.
-
Investigating ALE.P02 for treating specific solid tumors in adults
This study is testing a new treatment called ALE.P02 to see if it can safely help adults with advanced solid tumors that have a specific marker called Claudin-1.
-
External and internal radiation plus chemotherapy and immunotherapy for Stage IVB cervical cancer
This trial will try adding external beam radiation and brachytherapy to chemotherapy (cisplatin and paclitaxel) plus immunotherapy (pembrolizumab and bevacizumab) to see if it is safe and helps people with newly diagnosed Stage IVB cervical cancer.
-
Testing a new antibody treatment for advanced squamous cell cancers
This study is testing a new antibody treatment combined with chemotherapy for people with advanced squamous cell cancers that haven't responded to standard therapies.
Related topics
Quick answers
How many Cervical Squamous Cell Carcinoma clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in United States (4 trials), Singapore (3 trials), Taiwan (3 trials), France (2 trials), Hong Kong (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 4, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.